CHPA Identifies Six Qualities Of Ideal FDA Commissioner To Trump's Team

January 17, 2017 at 8:41 PM
Strong medical scientific expertise, knowing how to balance benefit-risk tradeoffs and a vision for the future of health technologies are among the necessary qualities an ideal FDA Commissioner must have, stated a letter sent by the Consumer Healthcare Products Association to President-elect Donald Trump's Presidential Transition Team Dec. 21, 2016. The letter, obtained by Inside Health Policy, lays out six qualities the trade group says are needed by the next FDA commissioner in order to fulfill the agency's mission...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.